Despite major advances in HIV testing, early detection of infection at the point of care (PoC)
remains a key challenge. Although rapid antibody PoC and laboratory-based nucleic acid …

Nanobodies or VHH (variable domains of heavy-chain only antibodies) are derived from
camelid species such as llamas and camels. Nanobodies isolated and selected through …

With more than 6.9 M confirmed cases and∼ 400K deaths as on June 8, 2020 (1), COVID-
19, ushered in by the SARS-CoV-2 has projected itself as a microscopic-holocaust, much …

A plethora of different electronic and optoelectronic devices have been developed lately, for
biosensing applications (eg, label‐free, fast, and easier to operate) based on a detecting …

The development is reported of an ultra-rapid, point-of-care diagnostic device which
harnesses surface acoustic wave (SAW) biochips, to detect HIV in a finger prick of blood …

The control of cell movement through manipulation of cytoskeletal structure has therapeutic
prospects notably in the development of novel anti-metastatic drugs. In this study, we …

The COVID-19 pandemic has driven biotechnological developments to provide new and
more effective tools for prophylaxis, diagnosis, and therapy. Historically, monoclonal …

Nanobodies are highly affine binders, often used to track disease‐relevant proteins inside
cells. However, they often fail to interfere with pathobiological functions, required for their …

The HIV-1 capsid is an ordered protein shell that houses the viral genome during early
infection. Its expansive surface consists of an ordered and interfacing array of capsid protein …

Single-domain antibodies, derived from camelid heavy antibodies (nanobodies) or shark
variable new antigen receptors, have attracted increasing attention in recent years due to …